Cara Therapeutics (NASDAQ: CARA) isn't profitable and probably won't be for quite a while. The company lost over $27 million in the first quarter. It doesn't have a product on the market yet. Cara's ...

Hedge funds are known to underperform the bull markets but that's not because they are bad at investing. Truth be told, most hedge fund managers and other smaller players within this industry are very ...

Sometimes we get the weirdest emails. For example, a few weeks ago someone asked me if I wanted to try the Smart CARA (the Food Cycler in the U.S.), a Korean composting machine that turns food waste ...

Of all the hassles of recycling, the food waste bin is the worst. It sits by the sink, a lowering and squalid presence, gathering a nauseating mix of detritus: egg shells, apple cores, chicken bones, ...

Don't worry about the recent pullback in Cara Therapeutics' share price. Here's why the stock remains a buy. Cara Therapeutics (CARA) isn't profitable and probably won't be for quite a while. The ...

Hedge funds are known to underperform the bull markets but that’s not because they are bad at investing. Truth be told, most hedge fund managers and other smaller players within this industry are very ...